CIENCIAS DE LA SALUD

2006

1. A longitudinal study of patients with Parkinson's disease (ELEP): Aims and methodology

   Revista de Neurologia, Vol. 42, Núm. 6, pp. 360-365

2. A pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-Sleep

   Revista de Neurologia, Vol. 43, Núm. 10, pp. 577-583

3. Aberrant forkhead box O1 function is associated with impaired hepatic metabolism

   Endocrinology, Vol. 147, Núm. 12, pp. 5641-5652

4. Anticolinesterásicos en el tratamiento de la enfermedad de Alzheimer

   Revista de neurología, Vol. 42, pp. 471-477

5. Blockade of nicotinic receptors of bovine adrenal chromaffin cells by nanomolar concentrations of atropine

   European journal of pharmacology, Vol. 535, Núm. 1-3, pp. 13-24

6. Creación y protocolo de seguimiento longitudinal de una cohorte multipropósito de pacientes con enfermedad de Parkinson de reciente diagnóstico: Proyecto VIP

   Revista de Neurologia, Vol. 43, Núm. 6, pp. 366-373

7. Cuidados enfermeros en las personas sometidas a cirugía bariátrica

   Metas de enfermería, Vol. 9, Núm. 6, pp. 16-20

8. DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production

   Blood, Vol. 107, Núm. 10, pp. 3950-3958

9. Effect of donepezil on motor and cognitive function in Huntington disease

   Neurology, Vol. 67, Núm. 7, pp. 1268-1271

10. Estudio de las variables clínicas asociadas y fenomenología de las alucinaciones en la enfermedad de Parkinson

    Neurologia, Vol. 21, Núm. 1, pp. 12-18

11. Global versus factor-related impression of severity in Parkinson's disease: A new clinimetric index (CISI-PD)

    Movement Disorders, Vol. 21, Núm. 2, pp. 208-214

12. Identification and characterization of human polyserase-3, a novel protein with tandem serine-protease domains in the same polypeptide chain

    BMC Biochemistry, Vol. 7

13. Impact of fatigue in Parkinson's disease: The fatigue impact scale for daily use (D-FIS)

    Quality of Life Research, Vol. 15, Núm. 4, pp. 597-606

14. Motor function in Parkinson's disease and supranuclear palsy: Simultaneous factor analysis of a clinical scale in several populations

    BMC Medical Research Methodology, Vol. 6

15. No association of apolipoprotein E ε4 genotype with faster progression or less recovery of relapses in a Spanish cohort of multiple sclerosis

    Multiple Sclerosis, Vol. 12, Núm. 1, pp. 13-18

16. RUNX3 negatively regulates CD36 expression in myeloid cell lines

    Journal of Immunology, Vol. 177, Núm. 4, pp. 2107-2114

17. Rapamycin-mediated inhibition of mammalian target of rapamycin in skeletal muscle cells reduces glucose utilization and increases fatty acid oxidation

    Metabolism: Clinical and Experimental, Vol. 55, Núm. 12, pp. 1637-1644

18. p38 mitogen-activated protein kinase mediates the fas-induced mitochondrial death pathway in CD8+ T cells

    Molecular and Cellular Biology, Vol. 26, Núm. 6, pp. 2118-2129